Phase Bioscience appoints Craig Rosen executive chairman

David Ranii, Staff Writer Comment on this story MORRISVILLE - Drug development company Phase Bioscience has named biotechnology industry heavy hitter Craig Rosen its executive chairman. Rosen, 50, is former president and chief scientific officer of Human Genome Sciences and co-founder, chief scientific officer and executive chairman of CoGenesys, which Teva Biopharmaceuticals acquired for $400 million earlier this year. Rosen, who got to know Phase Bio CEO Chris Prior when Human Genome Sciences acquired a company founded by... [read full story]